3.4(top 10%)
impact factor
15.2K(top 1%)
papers
240.0K(top 2%)
citations
141(top 5%)
h-index
3.5(top 10%)
impact factor
26.8K
all documents
303.0K
doc citations
198(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Targeting PI3K/Akt/mTOR Signaling in CancerFrontiers in Oncology20141,077
2Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and LimitationsFrontiers in Oncology2018926
3Implications of the Hybrid Epithelial/Mesenchymal Phenotype in MetastasisFrontiers in Oncology2015581
4Role of Matrix Metalloproteinases in Angiogenesis and CancerFrontiers in Oncology2019570
5Lactate in the Regulation of Tumor Microenvironment and Therapeutic ApproachesFrontiers in Oncology2019522
6Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACiFrontiers in Oncology2018506
7Radiation-induced brain injury: A reviewFrontiers in Oncology2012501
8Targeting PI3K/mTOR Signaling in CancerFrontiers in Oncology2014450
9Trastuzumab: Updated Mechanisms of Action and Resistance in Breast CancerFrontiers in Oncology2012427
10Tumor-Associated Macrophages: Recent Insights and TherapiesFrontiers in Oncology2020401
11DNA Methyltransferases: A Novel Target for Prevention and TherapyFrontiers in Oncology2014393
12Targeting Macrophages in Cancer: From Bench to BedsideFrontiers in Oncology2018385
13Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical PracticeFrontiers in Oncology2019385
14Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and TherapyFrontiers in Oncology2019384
15Mitochondrial Dysfunction in CancerFrontiers in Oncology2013382
16The KEAP1–NRF2 System in CancerFrontiers in Oncology2017370
17Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor MicroenvironmentFrontiers in Oncology2014363
18Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational ResearchFrontiers in Oncology2013358
19PTEN: Multiple Functions in Human Malignant TumorsFrontiers in Oncology2015356
20Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO ClassificationFrontiers in Oncology2017343
21Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck CancerFrontiers in Oncology2015318
22Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in HepatocarcinomaFrontiers in Oncology2019309
23Altered Tumor-Cell Glycosylation Promotes MetastasisFrontiers in Oncology2014308
24Exploratory Study to Identify Radiomics Classifiers for Lung Cancer HistologyFrontiers in Oncology2016306
25The Keap1–Nrf2 system in cancers: stress response and anabolic metabolismFrontiers in Oncology2012305
26Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic ApplicationsFrontiers in Oncology2018305
27Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?Frontiers in Oncology2019302
28Microtubules and Their Role in Cellular Stress in CancerFrontiers in Oncology2014296
29The Global Landscape of EBV-Associated TumorsFrontiers in Oncology2019289
30Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in CancerFrontiers in Oncology2018283
31“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling PathwayFrontiers in Oncology2018283
32Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and MetastasisFrontiers in Oncology2018268
33The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell PlasticityFrontiers in Oncology2018267
34Clinical Overview of MDM2/X-Targeted TherapiesFrontiers in Oncology2016266
35Recent Advances in the Treatment of Breast CancerFrontiers in Oncology2018263
36Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell FateFrontiers in Oncology2017261
37Control of the Immune Response by Pro-Angiogenic FactorsFrontiers in Oncology2014260
38Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting TumorigenesisFrontiers in Oncology2020260
39Radiation as an immunological adjuvant: current evidence on dose and fractionationFrontiers in Oncology2012259
40Radiation-Induced Oral MucositisFrontiers in Oncology2017257
41Targeting Oncogenic Mutant p53 for Cancer TherapyFrontiers in Oncology2015249
42Fluorescence-Guided SurgeryFrontiers in Oncology2017249
43CRISPR Gene Therapy: Applications, Limitations, and Implications for the FutureFrontiers in Oncology2020247
44Vascular Permeability and Drug Delivery in CancersFrontiers in Oncology2013246
45Immuno-Oncology: Emerging Targets and Combination TherapiesFrontiers in Oncology2018244
46Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and HepatocarcinogenesisFrontiers in Oncology2018243
47Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody TherapyFrontiers in Oncology2018238
48Gene Therapy Leaves a Vicious CycleFrontiers in Oncology2019236
49Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative MechanismsFrontiers in Oncology2015232
50Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network AnalysisFrontiers in Oncology2018231